Pacific Biosciences of California Inc reports results for the quarter ended in December - Earnings Summary

Pacific Biosciences of California

16/02/2023 22:02

* Pacific Biosciences of California Inc  PACB.OQ  reported a
quarterly adjusted loss of 37 cents​​ per share for the quarter
ended in December. The mean expectation of eight analysts for
the quarter was for a loss of 36 cents per share.
    * Revenue fell 24.1% to $27.35 million from a year ago;
analysts
expected $26.24 million. 
    * Pacific Biosciences of California Inc's reported EPS for
the
quarter was a loss of 37 cents​.
    * The mean earnings estimate of analysts had fallen by
about 2.2%
in the last three months.​ 
    * In the last 30 days two analysts negatively revised
earnings
estimates 
    * Pacific Biosciences of California Inc shares had risen
by 35.6%
this quarter.
    * The company reported a quarterly loss of $84.38 million.
    * Wall Street's median 12-month price target for Pacific
Biosciences of California Inc is $12.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 5
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data February
16 at 10:02 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      -0.36          -0.37          Missed
 Sep. 30 2022      -0.33          -0.34          Missed
 Jun. 30 2022      -0.32          -0.32          Met
 Mar. 31 2022      -0.31          -0.37          Missed